Biosimilars: State of Clinical and Regulatory Science
On May 12, 2017, various issues and challenges associated with biologics were discussed during a session of the annual joint conference of Canadian Society for Pharmaceutical Sciences and Canadian Chapter of Controlled Release Society at Hyatt Regency Hotel, Montréal, QC, Canada. An update on the C...
Saved in:
Main Authors: | Agnes Victoria Klein (Author), Jian Wang (Author), Brian G. Feagan (Author), Mark Omoto (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012) -
Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013) -
A Regulatory Perspective on Biosimilar Medicines
by: Marta Agostinho Cordeiro, et al.
Published: (2024) -
Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
by: Beverly Ingram, et al.
Published: (2021) -
Current regulatory and market environment for biosimilars in Serbia
by: Pejović Gordana, et al.
Published: (2014)